BesaGov

Contract W81K0020A0014

Pharmalucence, Inc. · Department Of Defense · September 4, 2021

Order Dependent (Idv Allows Pricing Arrangement To Be Determined Separately For Each Order)NAICS 325412

Pharmalucence, Inc. was awarded a federal contract by Department Of Defense (Department Of The Army) on September 4, 2021 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It uses order dependent (idv allows pricing arrangement to be determined separately for each order) contract pricing. If all options are exercised, the contract could reach $1.00 million.

Potential value
$1.00M
if all options exercised
Modifications
0
Base award only

Contract details

PIID
W81K0020A0014
Award type
—
Pricing
Order Dependent (Idv Allows Pricing Arrangement To Be Determined Separately For Each Order)
NAICS
325412 · Pharmaceutical Preparation Manufacturing
Product / service
Medical And Surgical Instruments, Equipment, And Supplies
First action
September 4, 2021

Description

RADIOPHARMACEUTICAL TO MTFS

Modification timeline

  • September 4, 2021
    Mod P00002 · Other Administrative Action
    $0

Top contractors in NAICS 325412

Lifetime obligated dollars across all federal contracts in this NAICS code.

#ContractorContractsObligated
1Mckesson Corporation1,187$4.96B
2Merck Sharp & Dohme Llc26$894.71M
3Sanofi Vaccines Us Inc.57$702.38M
4Pfizer Inc169$541.15M
5Glaxosmithkline, Llc14$505.04M
6Phlow Corp.1$105.27M
7Exelan Pharmaceuticals Inc76$104.30M
8Seqirus USA Inc47$59.15M
9Emergent Biosolutions Canada Inc2$53.73M
10Mckesson Specialty Distribution Llc1$51.05M

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract W81K0020A0014?

Contract W81K0020A0014 is a federal contract awarded to Pharmalucence, Inc. by Department Of Defense on September 4, 2021 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.

Who won contract W81K0020A0014?

Pharmalucence, Inc. won contract W81K0020A0014 from Department Of Defense.

How much is contract W81K0020A0014 worth?

Contract W81K0020A0014 has obligated $0 to date but carries a potential ceiling of $1.00 million if fully funded and all options are exercised.